4,4,5,5-Tetramethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-bicyclo[1.1.1]pentanyl]-1,3,2-dioxaborolane, 97%, 500mg

Methyl biphenyl-2-carboxylate, 97.0%, 1g

5-methyl-4-isoxazolecarbonitrile, 95.0%, 5g

1-(4-Fluoro-3-methylphenyl)ethan-1-amine hydrochloride, 95%, 100mg

6-Chloroquinoline, 98.0%, 25g

4,4,5,5-Tetramethyl-2-[4-(10-phenylanthracen-9-yl)phenyl]-1,3,2-dioxaborolane>95.0%(HPLC)(T)200mg

N-{2-[(2-hydroxyphenyl)amino]-3,4-dioxocyclobut-1-en-1-yl}-2-methylpropane-2-sulfinamide, 97.79%, 100mg

Sodium hydroxide solution 5%, extra pure, 2.5 l, plastic packaging.

7-(But-2-yn-1-yl)-8-ethoxy-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity), 97%, 50mg

1,3-Diphenylguanidine, 95.0%, 100g

2,4-DICHLORO-6,7-DIMETHOXYQUINOLINE, 95.0%, 5g

2-Fluoro-5-methylbenzenesulfonyl chloride, 95.0%, 250mg

2-(dimethyl-1,3-thiazol-5-yl)ethan-1-ol, 97%, 1g